Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study

Dassah, Sylvester; Sakyi, Samuel A.; Frempong, Margaret T.; Luuse, Arnold T.; Ephraim, Richard K. D.; Anto, Enoch O.; Oduro, Abraham

dc.contributor.author	Dassah, Sylvester
dc.contributor.author	Sakyi, Samuel A.
dc.contributor.author	Frempong, Margaret T.
dc.contributor.author	Luuse, Arnold T.
dc.contributor.author	Ephraim, Richard K. D.
dc.contributor.author	Anto, Enoch O.
dc.contributor.author	Oduro, Abraham
dc.date.accessioned	2022-06-13T10:42:09Z
dc.date.available	2022-06-13T10:42:09Z
dc.date.issued	2015-12
dc.identifier.issn	23105496
dc.identifier.uri	http://hdl.handle.net/123456789/8314
dc.description	10p:, ill.	en_US
dc.description.abstract	Hepatitis B Virus (HBV) infection is an important public health problem that requires high priority efforts towards prevention and control. Active immunization is the single most important and effective preventive measure against HBV infection. As a protective measure, Ghana introduced the mass immunization program against hepatitis B infection in children in 2002 in her Expanded Programme on Immunization (EPI). This study evaluated seroconversion (the point in time when the amount of antibody in the blood becomes detectable) and seroprotection (the point in time when the amount of antibody in the blood is enough to confer protection from the antigen that induced it production) status of children under this mass immunization program and measured their antibody levels five years after immunization.	en_US
dc.language.iso	en	en_US
dc.publisher	University of Cape Coast	en_US
dc.title	Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study	en_US
dc.type	Article	en_US